ag 1879 has been researched along with Di Guglielmo Disease in 2 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilson, MB | 1 |
| Schreiner, SJ | 1 |
| Choi, HJ | 1 |
| Kamens, J | 1 |
| Smithgall, TE | 1 |
| Kosmider, O | 1 |
| Denis, N | 1 |
| Lacout, C | 1 |
| Vainchenker, W | 1 |
| Dubreuil, P | 1 |
| Moreau-Gachelin, F | 1 |
2 other studies available for ag 1879 and Di Guglielmo Disease
| Article | Year |
|---|---|
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Topics: Apoptosis; Cell Division; Cell Transformation, Neoplastic; DNA-Binding Proteins; Dose-Response Relat | 2002 |
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
Topics: Animals; Benzamides; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Disease Progression | 2005 |